INTRODUCTION
The homeotic genes of insects and the Hox genes of vertebrates are evolutionarily related families represented over a broad range of animal species (2) . Homeotic and Hox genes exert their effects through the transcriptional regulation of target genes, few of which have been identified. The best characterized example is the Drosophila homeotic gene Deformed {Dfd). The Dfd protein has been shown to positively regulate the expression of its own gene (3) . A minimal Dfd autoregulatory enhancer has four high affinity Dfd binding sites (4) .
DNA-binding is mediated by the 61 residue homeodomain encoded by the highly conserved homeobox (5-7) and found in the C-terminal half of the protein. Apart from the homeodomain, other regions of the Hox and homeotic gene products are also conserved. Most notable is the so-called conserved pentapeptide (8, 9) , a domain found just N-terminal to the homeodomain of many Antp class homeoproteins. Regions of some conservation are also found immediately C-terminal to the homeodomain and at the extreme N-terminus (2) . The extent of homology is greatest amongst members of the same subfamily.
Other regions can be identified based on amino acid content or character, rather than percent identity. For example, homeoproteins of the Dfd subfamily have a proline-rich region in the N-terminal half of the molecule (10) (11) (12) . The C-terminus of the mouse HOXD-4 protein is very serine-rich (10) . Determining the roles of these regions is an important approach to understanding differential function among the Hox gene products.
Via transient transfections of P19 embryonal carcinoma (EC) cells, we have recently identified an autoregulatory element of the murine Hoxd-4 gene (1). This activity provided us with an assay by which to assess the functional contributions of regions within the HOXD-4 homeoprotein to transcriptional activation. In a complementary test, HOXD-4 residues were fused to the GAL4 DNA-binding domain to map transcriptional activation functions. Using these approaches, we have shown that many regions of HOXD-4 are dispensable for activation of the Hoxd-4 promoter in our assay. The proline-rich N-terminus of HOXD-4 is a strong transcriptional activation domain.
MATERIALS AND METHODS Piasmids
We use the recently adopted Hox nomenclature (13) . Old Hox names are given in brackets on first use. Two sequencing errors and an error in the Hoxd-4 cDNA were included in the previously published sequence of Hoxd-4 (10) . The corrected sequence results in the following changes: G39 to S39, R95 to P95, and P192 to S192 (Fig. 1 ). Note that with S192 the sequence of the HOXD-4 homeodomain now shares 100% identity with that of human HOXD4 (9) . The sequence of Hoxd-4 in the GenBank database has been revised appropriately (accession number J03770).
Hoxd-4 expression vectors were based on the murine phosphogtycerate Hnase-1 (pgk-1) promoter and 3' processing sequences (14) which were a kind gift of Dr Michael McBurney. Hoxd-4 coding region sequences were obtained from cDNA and genomic clones (10) and inserted between the pgk-1 elements in pBluescribe (Stratagene). The unique Xho I, Bam HI, and Xba I sites (Fig. 2) were engineered via PCR-mediated mutagenesis and standard recombinant DNA techniques.
• To whom correspondence should be addressed at: McGill Cancer Center, Room 714, 3655 Drummond Street, Montreal, Quebec H3G 1Y6, Canada Sequences naturally flanking the ATG of the third codon conform to a Kozak consensus (15) whereas those for the first codon do not (10) , suggesting that translation of Hoxd-4 transcripts begins with the methionine at position 3 ( Fig. 1) . Creation of the Bam HI site involved restriction at a Bal I site and removed approximately 300bp of leader sequence and the upstream initiation codon (Ml) (Fig. 1) . The Kozak consensus at the initiation codon for M3 was lost in this process. A Kozak consensus sequence was restored by site-directed mutagenesis to give the expression vector p4.2 (Table 1) . p4.2-transfected cells synthesize a product recognized by polyclonal antibodies directed against the HOXD-4 N-and C-termini (Fig. 3) . The apparent size of this protein on Western blots is larger than expected, also noted for the products of the chicken Hoxd-4 and Hoxa-4 homologs which are also proline-rich (16 Derivatives of p4.2 mutated in the Hoxd-4 coding region were generated by oligonucleotide-directed mutagenesis on singlestranded DNA (deletions and substitutions) and by standard recombinant DNA techniques ( Table 1 ). The procedure of Kunkel et al. (17) was used for site-directed mutagenesis. All mutants were verified by sequencing of double-stranded DNA by the chain termination method (18) . Mutant vectors gave products of appropriate size in Western blot analysis.
The construction of the luciferase reporter pSXAP2 under the control of the Hoxd-4 promoter/autoregulatory element is described elsewhere (1) . An expression vector for the GAL4 DNA binding domain (residues 1 to 148) was made from the vector pSG5Gal-VP16 (19) (kind gift of Dr John White) by enzymatic removal of VP16 coding sequences. Hoxd-4 coding sequences were introduced in frame with the Gal4 coding region. The GAL4-responsive luciferase reporter pXPAL7 was made by PCR amplification of the promoter region of the vector pAL7 (20) (kind gift of Dr John White) and transfer to the luciferase vector pXPl (21) . Luciferase reporter p34a was made by H.Popperl (unpublished). All constructs were verified by sequence analysis. The AP2 expression vector sp(RSV)AP2 was a kind gift of Dr Trevor Williams (22) .
Cell culture, transfections and enzymatic assays P19 EC cells were cultured and calcium phosphate transfection assays performed as described previously (1) . Transfections of differentiating cells were done 48 hours after retinoic acid (RA) addition to 3 x 10~7M. For assays on the Hoxd-4 promoter, each dish received 1/ig of expression vector, 4/xg of luciferase reporter pSXAP2, and 1/tg of pRSVlacZ as internal standard. For assays with GAM fusions, the amount of expression vector was reduced to lOOng. Precipitates for each 100mm dish were brought to 10/tg total DNA with supercoiled pBluescribe (Stratagene). All luciferase values were normalized to those for /3-galactosidase.
Antibody production and Western analysis
Fusions of the N-terminal half or C-terminal half of HOXD-4 to the amino terminus of trpE were accomplished through the pATH2 and pATH3 vectors, respectively (23) . Immunizations were according to Harlow and Lane (24) . Approximately 125/*g of each induced fusion protein were electroeluted from SDS/polyacrylamide gels, lyophilized, resuspended in 500/J water and emulsified with 5(Xtytl of complete Freund's adjuvant. Rabbits were injected subcutaneously at 4 sites each, 250/d per site. Boosts were given at 4 week intervals using incomplete Freund's adjuvant. Serum was obtained at the same time by ear bleeding (25ml) or by cardiac puncture 4 weeks after the third boost. Western blots were performed with Biorad minigel and minitransfer modules and a Biorad immunoblotting kit. A 1:100 dilution of the primary antibody was used with alkaline phosphatase-conjugated goat antirabbit second antibody. The availability of antisera independently directed against the HOXD-4 N-and C-termini allowed us to assess the levels of proteins mutated in one domain by using antiserum directed against the other, thus avoiding detection problems due to epitope loss.
RESULTS

The Hoxd-4 coding region
The HOXD-4 protein can be divided into 8 regions based on homologies within and beyond the Dfd subfamily of proteins, and on the basis of amino acid composition ( Fig. 1 ). We used these to guide a mutational analysis of HOXD-4 structure and function (Table 1) . To assay HOXD-4 activity, we relied on its ability to activate transcription through an autoregulatory element in the Hoxd-4 promoter in transient transfections of P19 EC cells (1) . The wild-type expression vector for HOXD-4 (p4.2) and the After transfection into pluripotent and RA-treated P19 cells, p4.2 directed the synthesis of a product reactive on Western blots with antibodies against HOXD-4 ( Fig. 3 ). Mutated derivatives of p4.2 were also examined for the production of immunoreactive species which were detected in all but four cases (Fig. 4) . One of these four was p4.2FS which had a frame shift mutation in the homeobox in the region coding for the recognition helix (Table  1 ; Fig. 2 ). Transcriptional activation by p4.2 and its mutated derivatives was expressed as the ratio of standardized luciferase activity over that obtained with p4.2FS.
Transcriptional activation by mutant HOXD-4 proteins
Site-specific binding by the homeodomain is in part mediated by the third a helix (recognition helix) which makes contacts in the major groove (25) (26) (27) (28) (29) (30) (31) (32) . A key determinant of specificity is the residue at position 50 of the homeodomain, within the recognition helix (33) (34) (35) . Substitution for lysine converts the specificity of binding to that of the bicoid homeodomain (30) . As for all Hox and homeotic gene products, HOXD-4 has a glutamine at this position (Q201, Fig. 2 ). Conversion of this glutamine to lysine abrogated activation of die Hoxd-4 promoter (sbK201, Fig. 4 ) and abolished binding to a HOXD-4 binding site in an electrophoretic mobility shift assay (data not shown). Nonetheless, this protein gave a band intensity comparable to wild-type on Western blots. This result underscores the importance of the homeodomain in transcriptional activation by HOXD-4. The tryptophan at position 199 of HOXD-4 is highly conserved and has been implicated in homeodomain function by genetic and structural observations. Conversion to a tyrosine residue (sbY199, Fig. 4 ) resulted in the loss of a detectable product on Western blots and a severe reduction in transcriptional activation.
Deletion of conserved N-terminal regions B, or A plus B (dlB and dlAB, Fig. 1 and 4) , did not greatly affect HOXD-4 function, though the activity of dlAB was somewhat elevated. Products bearing deletions of much of the proline-rich region C or the entire N-terminal half of HOXD-4 could not be detected in Western analysis. A six amino acid deletion which removed four of the five amino acids of the conserved pentapeptide (8, 9) (dID, Fig. 1 and 4 ) was 2.6 fold more active for transcriptional activation in pluripotent P19 cells. A five amino acid deletion of the conserved region G immediately C-terminal to the homeodomain (dlG, Fig. 1 and 4 ) also caused a modest increase in HOXD-4 activity. Full deletion of the C-terminus, including the serine-rich region H (dlGH, Fig. 4 ), impaired the ability of HOXD-4 to activate the Hoxd-4 promoter. Replacement with the C-terminus of the paralogous Hoxa-4 (Hax-1.4) product (sbHA-4, Fig. 4 ) restored activation to wild-type levels. Results were similar in both pluripotent and RA-treated P19 cells. To ensure that transcriptional activation by HOXD-4 derivatives was mediated by the autoregulatory enhancer in the Hoxd-4 promoter, we tested three HOXD-4 vectors on two different promoters. One was a minimal adenovirus major late promoter, while the other had, in addition, the Hoxd-4 autoregulatory enhancer (1) . As shown in Table 2 , wild-type HOXD-4 as well as derivatives dID and dlG were considerably more active on the promoter containing the autoregulatory element (pNBML). Consistent with results on the Hoxd-4 promoter (Fig. 4) , dID is more active than wild-type. We conclude that the effects of HOXD^t derivatives are mediated through the Hoxd-4 autoregulatory enhancer. "HOXD-4 and two derivatives, dID and dlG, were tested for specific activation through the autoregulatory enhancer in the Hoxd-4 promoter in RA-treated P19 cells. Appropriate expression vectors were tested at 1 /»g/100mm plate in cotransfections with luciferase reporters pML and pNBML. pML contains the adenovirus major late promoter. In pNBML, the 217bp NruJ/BamHI fragment containing the Hoxd-4 autoregulalory element has been inserted just upstream of the adenoviral TATA box (1) . 'The fokl increase over basal promoter activity mediated by HOXD-4 expression vectors is shown. The ratio of fold activation obtained with pNBML over pML. 
A transcriptional activation domain in the HOXD-4 Nterminus
While the intact yeast GAL4 protein is a strong transcriptional activator of responsive promoters in eukaryotic cells, the isolated GAM DNA-binding domain is not. Fusion of the GAL4 DNAbinding domain to heterologous polypeptides thus provides an assay for transcriptional activation domains distinct from those involved in DNA binding (36) . HOXD-4 N-terminal regions A through D were fused to the GAL4 DNA-binding domain and tested for their ability to activate transcription from a GAL4-responsive reporter in differentiating P19 cells. As shown in Figure 5 , this fusion product (GAL/ABCD) was 250 times more active than GAL/ which has the GAL4 DNA-binding domain alone (507 fold vs 2 fold). This result maps one or more transcriptional activation domains to the proline-rich HOXD-4 N-terminus. •Acidic and proline-rich transcrpitkmal activators were tested for their ability to squelch activation by HOXD-4 and by three GAM chimeras. Combinations of activating proteins and luciferase reporters are given on top. pSXAP2 carries the Hoxd-4 promoter (Fig. 2B) . p34a has multiple HOXD-4 binding sites upstream of the adeoovirus major late promoter. pXPAL7 has 5 palindromic binding sites for GAL4 placed upstream of the adenovirus major late promoter ( Deletion of regions A and B from HOXD-4 had no effect on transcriptional activation (Fig. 4) , indicating a role for regions C or D in N-terminal function. Fusion of the GAL4 DNA-binding domain to just a portion of the proline-rich region C (GAL/C; residues 24 to 109) also increased activation GAL/ (Fig.5) . This suggests that region C spans a transcriptional activation domain of the proline-rich variety (37) .
Deletion and substitution mutants suggested a role in transcriptional activation for the HOXD-4 C-terminus and the equivalent region of the Hoxa-4 product (Fig. 4) . However, fusion of the GAL4 DNA-binding domain to the HOXD-4 Cterminus (GAL/H) had no effect on transcriptional activation (Fig.  5) . A similar result was obtained with the HOXA-4 C-terminus (GAL/HA^t). Coexpression of either of these products with GAL/ABCD did not result in any synergistic activation of reporter gene expression (not shown). The role of these Cterminal sequences thus remains to be determined.
The transcription factor AP2 has been shown to harbor a transcriptional activation domain of the proline-rich variety (22) and would be expected to squelch the activity of HOXD-4, if HOXD-4 also contains a proline-rich activation domain. Cotransfections with an expression vector for the AP2 transcription factor revealed an inhibition of HOXD-4 activity on both artificial and Hoxd-4 promoters (Table 3) . By contrast, a GAL/VP16 expression vector did not squelch the activity of HOXD-4 on the Hoxd-4 promoter (Table 3 ). In fact, we note a two fold increase in luciferase activity in this case. This is not due to an effect of GAL/VP16 on the Hoxd-4 promoter (data not shown). Cotransfections with a luciferase reporter under the control of the pgk-1 promoter showed a 10 and 50% repression by 0.4 and 1.0/tg of AP2 expression vector, respectively. It is thus possible that AP2 may be decreasing the production of HOXD-4 from thepg)fc-7-based expression vector. However, this could not account for the repressive effects of AP2 on HOXD-4 activity since decreasing the amount of the HOXD-4 expression vector by 2 fold does not decrease activation of the Hoxd-4 promoter (data not shown).
Activation of the GAL4-responsive reporter by GAL/ABCD and GAL/C was also inhibited by cotransfection with the AP2 expression vector (Table 3) . AP2 did not significantly squelch the activity of the acidic activator GAL/VP16. Because all GAL4 constructs were expressed from the same promoter, these differences cannot be accounted for by differential effects of AP2 on the expression of Ga/4-containing genes. These results suggest that AP2 is able to squelch HOXD-4 activity due to competition for mutually required auxiliary factors necessary for the function of proline-rich, but not acidic, transcriptional activation domains.
DISCUSSION
HOXD-4 activates transcription from an autoregulatory element in Hoxd-4 upstream sequences in transient transfections of P19 cells (1) . We used this activity to assess the effects of various deletion and substitution mutations of the Hoxd-4 coding region. Fusions to the GAL4 DNA-binding domain were also used to assay regions of the HOXD-4 protein for transcriptional activation domains.
The importance of the DNA-binding homeodomain for HOXD-4 activity was clearly established by a single residue change within the recognition helix; conversion of glutamine at position 201 to lysine, a change expected to alter binding-site specificity (34, 35) , abrogated transcriptional activation by HOXD-4. We have confirmed that this mutation impairs recognition of the HOXD-4 binding site in band shift assays (not shown). We conclude that the activation of the Hoxd-4 promoter by HOXD-4 requires the homeodomain, unlike some homeodomain-independent activities noted for other proteins (38, 39) .
A pentapeptide motif (consensus VYPWM) (8, 9) is located N-terminal to the homeodomain in Antp class homeoproteins and in the labial subfamily. It is not present in Abd-B, nor in Abd-B-like vertebrate proteins described to date (40) . In our assay we did not observe a dramatic change in activity upon deletion of the pentapeptide motif (Fig. 4) . Though a possible explanation is that P19 EC cells lack cofactors which could modulate homeoprotein activity through the pentapeptide motif, we obtained similar results in transfections of differentiated P19 cells (Fig. 4) . We were also unable to detect activity for conserved regions A and B at the extreme N-terminus of HOXD-4. Conservation suggests function, therefore we conclude that transient transfections of P19 cells cannot reveal all the biochemical activities of homeoprotein molecules.
C-termini have been implicated in quantitative roles in homeoprotein function (41) . Deletion of residues C-terminal to the HOXD-4 homeodomain (dlGH, Fig. 4 ) reduced activity on the Hoxd-4 promoter, and this could be rescued by replacement with the HOXA-4 C-terminus. However, neither was able to confer activity on the GAL4 DNA-binding domain (GAL/H and GAL/HA^, Fig. 5 ). Nor did they cooperate with the HOXD-4 N-terminus in cotransfections with GAL/ABCD (not shown). Others report a mild (4 fold) increase in HOXD-4 activity upon deletion of regions G and H (42). However, these earlier studies made use of high levels of transfected Hoxd-4 expression vectors (5/xg/plate) in HeLa cells. We have also noted 4 to 6 fold increases over wild-type in the activity of HOXD^J C-terminal deletions at ^4/tg/plate of transfected expression vector (unpublished observations). The significance of these increases at such high vector concentrations is not clear.
In Dfd, the region N-terminal to the homeodomain is 365 residues long, whereas in HOXD-4 it is 149 residues. Within these regions, there is little sequence conservation apart from the extreme amino terminus and the region of the pentapeptide. Moreover, we have no direct evidence for transcriptional activation domains in either of these conserved regions. Nterminal to the homeodomain, Dfd has regions up to 10% in proline, but has domains richer in histidine, serine, glycine and acidic residues (43) . By contrast, the HOXD-4 N-terminal half is proline-rich and displayed strong transcriptional activation function when fused to the GAL4 DNA-binding domain (GAL/ABCD, Fig. 5 ). Region C of HOXD-4 is 21 % in proline. A 74 residue stretch of region C (residues 48 to 121) is 30% proline. Most of region C was fused to the GAL4 DNA-binding domain and conferred an 11 fold activation above background (GAL/C, Fig. 5 ). This is less than with the whole HOXD-4 Nterminus (371 fold), but comparable to that seen with the CTF/NF-1 proline-rich region fused to the SP1 DNA-binding domain (5 fold) (44) .
The decreased activity of GAL/C suggests additional activity in regions A, B or D. However, deletion of these regions did not impair HOXD-4 function (Fig. 4) . It should be noted that 7 proline residues between positions 109 and 141 are missing from GAL/C, and the absence of this stretch may have been detrimental. Moreover, using extracts of transiently transfected cells, GAL/C gave a less intense retarded band than GAL/ABCD in electrophoretic mobility shift assays with a GAL4 binding site (not shown). It is thus not clear for the moment whether the reduced activity of GAL/C relative to GAL/ABCD is due to the loss of complementing residues. A HOXD-4 protein containing a duplication of residues 6 to 81 appears to be much more active than the wild-type protein (42) . This stretch is proline-and glycine-rich and straddles much of the region we have called C, supporting a role for these residues in transcriptional activation.
Squelching (45) is a phenomenon whereby one transcription factor can inhibit the activity of another independent of both its ability to bind DNA and to directly interact with the inhibited protein. AP2 has a proline-rich transcriptional activation domain (22) and is able to squelch HOXD-4 activity, but not that of the acidic transcriptional activator GAL/VP16 (Table 3) . Neither is GAL/VP16 able to squelch HOXD^J. These data support the presence of functionally similar proline-rich transcriptional activation domains in AP2 and HOXD-4 that are distinct from that of GAL/VP16. AP2 expression overlaps with that of many Hox genes both spatially and temporally in development. Tissues expressing both include neural crest, limb bud mesenchyme and the meso-and metanephros (46) . Overlapping expression and similar proline-rich transcriptional activation domains may suggest cooperation between HOX proteins and AP2 in embryonic patterning.
Our results strongly suggest that a transcriptional activation domain of the proline-rich type (37) contributes to the activity of the HOXD-4 N-terminus, and that proline-rich domains of other homeoproteins may function in a similar capacity. HOX proteins with proline-rich N-terminal regions (s 20% over at least 60 residues) include the HOXD-4 paralogs HOXA-4 (11), HOXB-4 (12) and HOXC-4 (47) . Others have suggested that the proline-rich N-terminus of chicken HOXA^l functions as a transcriptional activator, though their results are difficult to interpret due to competitive effects on the high endogenous activity of a Jun-responsive reporter (48) . By contrast, the background in our GAL-4 assay is low.
Dfd itself does not have proline-rich domains. Nonetheless, human H0XD4 can substitute for Dfd for the activation of the Dfd transcription unit in flies (49) . In addition, the Dfd autoregulatory enhancer may respond to Dfd subfamily Hox products in mice (50) . These data suggest that for some of the genetic pathways regulated by Dfd subfamily members, transcriptional activation can be accomplished by disparate domains. We also note that many Hox genes do not encode proline-rich regions, suggesting that these proteins use functionally distinct transcriptional activation domains. In the embryo, where the products of multiple Hox genes may bind responsive enhancers in various combinations, the specific array of such regulatory domains could be an important determinant of the transcriptional response.
